Investment Rating - The report initiates coverage with a "Buy" rating for the company [11][13]. Core Insights - The company, Frontier Biotech, focuses on innovative drug development with a strong emphasis on technology and patent barriers, establishing a product portfolio that includes long-acting HIV drugs, new technology small nucleic acid drugs, and high-end generics [5][8]. - The company has developed a robust pipeline of small nucleic acid drugs targeting chronic diseases such as IgA nephropathy and dyslipidemia, with promising candidates FB7013 and FB7011 showing first-in-class (FIC) potential [9][31]. - The long-acting HIV drug, Aikening (ABT), has shown steady growth since its conditional approval in 2018 and received regular approval in 2023, with additional long-acting HIV products in development to strengthen the company's competitive position in the HIV treatment market [10][20]. Summary by Sections Company Overview - Frontier Biotech was established in 2013 and went public on the Shanghai Stock Exchange in 2020, focusing on unmet clinical needs in chronic disease treatment and building a dual-driven development model of innovative drugs and high-end generics [20][28]. Product Pipeline - The company has a diverse pipeline that includes long-acting HIV treatments and a variety of small nucleic acid drugs targeting diseases such as IgA nephropathy, high uric acid, and metabolic disorders [30][52]. - The small nucleic acid drugs are designed to regulate mRNA and have the potential to treat previously untreatable diseases, marking a significant advancement in drug development [31][35]. Financial Projections - Revenue forecasts for the company are projected at CNY 145 million, CNY 173 million, and CNY 210 million for the years 2025 to 2027, with net losses expected to decrease over the same period [11].

Investment Rating - The report indicates a positive outlook for the cleanroom sector, suggesting that the demand for cleanrooms is expected to continue increasing due to the semiconductor industry's growth [10]. Core Insights - The cleanroom shortage has garnered attention from various stakeholders in the semiconductor supply chain, including storage, wafer foundries, and equipment manufacturers, indicating a rising demand for cleanroom facilities [8][10]. - Major companies like Micron and Samsung are planning to invest in additional cleanroom capacity to meet the growing demand for advanced memory technologies, particularly HBM, which has a higher wafer consumption ratio compared to DDR5 [10]. - TSMC is also facing capacity constraints in its 3nm production due to high demand from companies like NVIDIA and AMD, leading to an anticipated increase in monthly production capacity despite cleanroom space limitations [10]. - Equipment manufacturers such as ASML, Lam Research, and KLA have reported that the physical capacity of wafer fabs is a significant constraint on expanding production to meet customer demand, with many fabs nearing full operational capacity [10]. Summary by Sections Semiconductor Storage Companies - Micron is shifting memory demand from DDR5 to HBM, which requires more cleanroom space, prompting plans for additional cleanroom investments [10]. - Samsung anticipates supply expansion limitations in 2026 and 2027 due to the scarcity of cleanroom space and is planning to invest in new wafer fabs to secure cleanroom capacity [10]. Wafer Foundries - TSMC is expected to increase its 3nm capacity by an additional 20,000 wafers per month, but is constrained by cleanroom space [10]. Equipment Manufacturers - ASML reported a revenue of €7.2 billion in Q4 2025, with CEO emphasizing that many fabs are operating at near full capacity, limiting new capacity releases due to land, power, and cleanroom space constraints [10]. - Lam Research achieved revenue of $5.1 billion, with management noting that existing fabs have little excess capacity, and new factory construction typically takes over two years [10]. - KLA reported a record revenue of $2.9 billion, with the CEO highlighting customer efforts to increase equipment density and process efficiency within limited space [10]. Market Outlook - The cleanroom sector is expected to see growth in both scale and profitability driven by AI-related semiconductor demand, with recommended investments in companies like Axiom Integration and Shenghui Integration overseas, and Deep Sanda A and Bocheng Co. domestically [10].

Investment Rating - The report maintains a "Positive" investment rating for the industry [9]. Core Insights - In the short term, the electricity gap in North America continues to widen, leading to a supply-demand imbalance for gas turbines, which presents an opportunity for gas generator sets to become the primary power source [3][8]. - In the medium to long term, gas generator sets are expected to be a superior choice for small to medium-sized data centers due to their advantages in mid-speed parallel operation and lower redundancy costs [6][52]. - Domestic companies like Weichai Power and Yinlun Co. are well-positioned to benefit from this opportunity due to their production capacity and quick delivery capabilities [3][8]. Summary by Sections Background - The demand for AI computing power has surged, resulting in a projected electricity gap of approximately 73.2 GW in the U.S. from 2025 to 2030, which could increase to 201 GW if data center growth exceeds expectations [5][22]. Demand - Gas generator sets are expected to experience explosive growth in the short term due to the electricity shortage, with a significant demand for approximately 9 GW of gas engines in North America by 2026 [6][49]. - The medium to long-term outlook indicates that gas generator sets will become the preferred choice for data centers, particularly those in the 100 MW range, due to their operational efficiency and cost advantages [52]. Supply - There is a notable shortage of gas generator capacity from overseas suppliers, while domestic companies like Weichai Power can deliver quickly and meet the growing demand [7][63]. - The current market leaders in gas engines include Caterpillar and Yanmar, with Caterpillar holding a significant market share [55][58]. Investment Recommendations - The report suggests a strong growth cycle for gas generator sets in North America, driven by the ongoing electricity shortage and the transition from gas turbines to gas generator sets as the primary power source [8][49].

Investment Rating - The report maintains a "Positive" investment rating for the industry [11]. Core Insights - The year 2025 marks a significant milestone for liquid cooling, with major manufacturers achieving substantial revenue growth and profitability due to the scale of liquid cooling product shipments [3][5]. - The AI wave, combined with the initial volume of liquid cooling, has led to record-high revenues for cooling-related manufacturers in Taiwan and Europe, with a notable increase in the proportion of liquid cooling-related income [30]. - The focus for 2026 will shift towards system integration, with major manufacturers expanding production capacity and emphasizing the need for complete solutions rather than just supply capabilities [6][32]. Summary by Sections Financial Overview - In 2025, AVC (奇鋐) achieved a revenue of 139.6 billion NTD, a 95% year-on-year increase, marking a historic high. The revenue for Q4 2025 was 47.8 billion NTD, up 129% year-on-year [16]. - Auras (双鸿) reported a revenue of 23.3 billion NTD for 2025, a 48% increase, with liquid cooling revenue accounting for over 30% of total income [18]. - Delta (台达电) reached a revenue of 554.9 billion NTD in 2025, a 32% increase, driven by the growth of liquid cooling products [24]. - Vertiv (维谛) generated a revenue of 10.23 billion USD in 2025, reflecting a 28% year-on-year growth, with significant contributions from the US market [28]. 2026 Outlook - The liquid cooling market is expected to continue its growth trajectory, with major manufacturers indicating that order visibility has extended to 2028 [6][32]. - The primary growth driver for liquid cooling in 2026 will be the demand for fully liquid-cooled NVIDIA products [33]. - Companies are focusing on enhancing their liquid cooling product offerings to transition into complete solution providers, shifting competition from supply capability to system integration [33]. Innovations and Trends - Current liquid cooling solutions predominantly utilize single-phase cold plates, but there is growing interest in innovative technologies such as micro-channel lids, which may offer improved cooling efficiency [51][52]. - The industry is exploring new cooling technologies, but single-phase cold plates are expected to remain the mainstream solution for the next few years due to their established supply chain and reliability [59]. Mergers and Acquisitions - The report notes ongoing mergers and acquisitions in the liquid cooling sector, with North American firms focusing on data center infrastructure while mainland Chinese firms are primarily involved in consumer electronics [8]. Investment Recommendations - The report recommends focusing on mainland manufacturers with unique capabilities that can leverage the growth in liquid cooling, particularly in the ASIC segment, which is expected to see increased penetration starting in Q3 2026 [9][39].

Investment Rating - The report maintains a "Positive" investment rating for the industry [2]. Core Insights - NLRP3 inflammasome is identified as a significant target for drug development due to its role as a "receiver and converter" of inflammatory signals, indicating substantial therapeutic potential [11][12]. - NLRP3 inhibitors, particularly VTX3232, have shown remarkable anti-inflammatory effects and preliminary validation for reducing cardiovascular (CV) risks [22][28]. - The market potential for targeting NLRP3 is significant, with a potential patient population of approximately 25 million in the cardiovascular anti-inflammatory drug scenario [39]. Summary by Sections 1. NLRP3 Inflammasome: A Major Drug Target - NLRP3 acts as an intracellular sensor detecting various microbial patterns and endogenous danger signals, leading to the assembly and activation of the NLRP3 inflammasome [11]. - The NLRP3 inflammasome is linked to several common diseases, including obesity, diabetes, and cardiovascular diseases, highlighting the market potential for NLRP3-targeted therapies [12]. 2. Efficacy of NLRP3 Inhibitors - VTX3232 demonstrated a rapid and significant reduction in high-sensitivity C-reactive protein (hsCRP) levels, with an 80% reduction within the first week and a sustained effect over 12 weeks [28]. - The safety profile of VTX3232 is comparable to placebo, with adverse events occurring at similar rates across treatment groups [29]. 3. Identifying Next-Generation NLRP3 Inhibitors - BGE-102, a novel NLRP3 inhibitor, has shown promising early-phase data, indicating its potential to lower hsCRP levels significantly in obese participants [65][67]. - The competitive landscape for NLRP3 inhibitors includes several active candidates, with BGE-102 being highlighted for its unique structure and mechanism [54].

NLRP3："抗炎"能力初步验证，心血管 领域又一潜在重磅靶点 ——美股生物科技前瞻系列 长江证券研究所医药研究小组 2026-02-25 %% %% %% %% research.95579.com 1 分析师及联系人 证券研究报告 • 证券研究报告 • 评级 看好 维持 分析师 彭英骐 分析师 刘长洪 SAC执业证书编号：S0490524030005 SAC执业证书编号：S0490525070007 SFC执业证书编号：BUZ392 %% %% %% %% research.95579.com 2 目 录 01 NLRP3炎症小体：炎症信号的"接收转化 器"，成药潜力巨大 02 NLRP3抑制剂抗炎效果突出，用于降低CV 风险初步验证 03 寻找下一个优质NLRP3抑制剂 04 风险提示 %% research.95579.com 3 01 NLRP3炎症小体：炎症信号的"接收转化器"， 成药潜力巨大 %% %% %% %% research.95579.com 4 NLRP3炎症小体是人体炎症信号的"接收转化器" %% %% %% %% research.95579.com 5 ➢ NLRP3是一种细胞 ...

Investment Rating - The industry investment rating is "Positive" and maintained [9] Core Viewpoints - The report emphasizes the strengthening expectation of price increases for electronic fabrics, driven by explosive demand and capacity constraints, indicating a "super cycle" characterized by strong demand rigidity and prolonged duration [5][6] - The report identifies three main lines for 2026: the stock chain, the Africa chain, and the AI chain, suggesting strategic focus areas for investment [8] Summary by Relevant Sections Basic Situation - Cement shipments are experiencing seasonal declines, with an average shipment rate of approximately 9% in key regions, a month-on-month decrease of about 15 percentage points, and a year-on-year decrease of about 4 percentage points [7][22] - Glass inventory has slightly increased, with a total inventory of 51.63 million weight boxes, a month-on-month increase of 2.14 million weight boxes, reflecting a 4.32% growth [7][30] Outlook for 2026 - The stock chain focuses on optimizing demand and clearing supply varieties, with residential renovation demand expected to rise from 50% currently to nearly 70% by 2030 [8] - The Africa chain highlights undervalued growth opportunities in the African market, recommending leading companies such as Keda Manufacturing and Huaxin Cement [8] - The AI chain looks at the industrial upgrade of special electronic fabrics, with a focus on Low-Dk products and domestic substitution opportunities [8] Price and Inventory - The national average price for cement before the festival was 346.29 yuan/ton, with a month-on-month decrease of 0.32 yuan/ton and a year-on-year decrease of 47.90 yuan/ton [23] - The national average price for glass before the festival was 63.24 yuan/weight box, with a month-on-month increase of 0.06 yuan/weight box and a year-on-year decrease of 11.07 yuan/weight box [32]

[Table_Summary] 我们认为，从练内功到带农户，从富农户到兴产业，德康农牧在生猪养殖行业探索了一条真正 实现联农带农和富农强农的产业振兴之路。深耕育种打牢养殖根基，成功构建起高壁垒的自主 繁育体系；二号农场重构养殖环节的生产关系，最大程度激发农户养殖的潜力和动能；"百村百 万"工程带动二号农场模式的快速落地，更好地赋能乡村振兴从而实现强农富农。在生猪养殖 行业进入高质量发展新时代，德康农牧以"不难不做"的企业基因，将行业难题系统性地转化 为自身强大的护城河，最终形成"低投入、高周转、高回报"的生猪养殖体系，持续重点推荐。 分析师及联系人 [Table_Author] 顾熀乾 陈佳 SAC：S0490519060003 SAC：S0490513080003 SFC：BQT624 [Table_scodeMsg1] 港股研究丨公司深度丨德康农牧（02419.HK） [Table_Title] 德康农牧深度系列二：联农标杆，富农典范 %% %% %% %% research.95579.com 1 丨证券研究报告丨 报告要点 请阅读最后评级说明和重要声明 2 / 28 %% %% %% %% resea ...

Investment Rating - The report maintains a "Positive" investment rating for the industry [10]. Core Insights - In the short term, the electricity gap in North America continues to widen, leading to a supply-demand imbalance for gas turbines, which presents an opportunity for gas generator sets to become the primary power source [3][9]. - In the medium to long term, gas generator sets are expected to become a preferred choice for small to medium-sized data centers due to their advantages in speed of delivery and operational efficiency [3][9]. - Domestic companies, such as Weichai Power and Yinlun Co., are well-positioned to benefit from this opportunity due to their production capacity and quick delivery capabilities [3][9]. Summary by Sections Background - The demand for AI computing power has surged, resulting in a projected electricity gap of approximately 73.2 GW in the U.S. from 2025 to 2030, which could increase to 201 GW if data center growth exceeds expectations [6][27]. Demand - Gas generator sets are expected to experience explosive growth in the short term due to the electricity shortage, with a projected demand of about 9 GW for gas generator sets in North America by 2026 [7][56]. - The medium to long-term outlook indicates that gas generator sets will be favored for their modularity and lower redundancy costs, particularly for data centers with capacities around 100 MW [8][58]. Supply - There is a significant supply shortage of gas generator sets from overseas manufacturers, while domestic companies like Weichai Power can deliver quickly due to their ample production capacity [8][73]. Investment Recommendations - The report suggests a strong growth cycle for gas generator sets in North America, driven by the ongoing electricity shortage and the limited supply of gas turbines [9][3].

丨证券研究报告丨 行业研究丨行业周报丨金属、非金属与采矿 [Table_Title] 假期金属价格走强，看好节后配置机遇 报告要点 [Table_Summary] 铜铝节后易涨难跌，重视板块机会。商品端，铜铝节后易涨难跌，中长期经济底部与逆全球化 促进供需结构优化，弹性可期：1）短期，美国对降息及铜关税态度，依然是短期工业金属价格 走势的主导因素，在二者并未发生根本性转变之前，维持铜铝趋势看涨判断，节后国内金三银 四旺季、中美会谈、联储主席换届等均构成催化；2）中期，美联储降息引领全球趋势宽松促进 铜铝周期上行；3）长期，逆全球化加剧各国对资源争夺，铜铝中枢趋势上行。 分析师及联系人 [Table_Author] 王鹤涛 肖勇 叶如祯 王筱茜 肖百桓 SAC：S0490512070002 SAC：S0490516080003 SAC：S0490517070008 SAC：S0490519080004 SAC：S0490522080001 SFC：BQT626 SFC：BUT918 SFC：BWM115 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 丨证券研究报 ...